BR112013022017A2 - formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica - Google Patents
formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêuticaInfo
- Publication number
- BR112013022017A2 BR112013022017A2 BR112013022017A BR112013022017A BR112013022017A2 BR 112013022017 A2 BR112013022017 A2 BR 112013022017A2 BR 112013022017 A BR112013022017 A BR 112013022017A BR 112013022017 A BR112013022017 A BR 112013022017A BR 112013022017 A2 BR112013022017 A2 BR 112013022017A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical formulation
- weight
- tablet
- producing
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 150000008163 sugars Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Abstract
formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica formulação farmacêutica sob a forma de grânulos que a) 60% a 96% em peso de açúcares não formadores de película ou alcoóis de açúcar, b) 1% a 10% em peso de açúcares formadores de ou alcoóis de açúcar, c) 3% a 25% em peso de agentes de desintegração, d) 0% a 10% em peso de polímeros formadores de película,insolúveis em água, e) 0% a 15% em peso, de outros excipientes farmacêuticos habituais, a soma dos componentes a) a e) sendo 100% em peso.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11157458 | 2011-03-09 | ||
| PCT/EP2012/053771 WO2012119997A1 (de) | 2011-03-09 | 2012-03-06 | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013022017A2 true BR112013022017A2 (pt) | 2016-11-29 |
Family
ID=45787220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013022017A BR112013022017A2 (pt) | 2011-03-09 | 2012-03-06 | formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2683365A1 (pt) |
| JP (1) | JP2014507454A (pt) |
| CN (1) | CN103415284B (pt) |
| BR (1) | BR112013022017A2 (pt) |
| WO (1) | WO2012119997A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3203975A1 (en) | 2020-12-03 | 2022-06-09 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
| CA3216359A1 (en) | 2021-04-07 | 2022-10-13 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| JP2024542726A (ja) * | 2021-12-02 | 2024-11-15 | ビーエーエスエフ ソシエタス・ヨーロピア | 直接打錠補助組成物 |
| AU2024353375A1 (en) | 2023-09-29 | 2026-04-09 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19615418A1 (de) * | 1996-04-22 | 1997-10-23 | Merck Patent Gmbh | Polyol-Zusammensetzung |
| JPH1020380A (ja) * | 1996-07-05 | 1998-01-23 | Minolta Co Ltd | カメラ |
| EP0839526A3 (en) | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| FR2781152B1 (fr) | 1998-07-20 | 2001-07-06 | Permatec Tech Ag | Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation |
| US20020071864A1 (en) | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
| US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| JP2004265216A (ja) | 2003-03-03 | 2004-09-24 | Seiko Epson Corp | 印刷装置、受信装置、中継装置、印刷システムおよび印刷方法 |
| US8647668B2 (en) * | 2003-10-15 | 2014-02-11 | Fuji Chemical Industry Co., Ltd. | Tablet quickly disintegrating in oral cavity |
| CN1732905A (zh) * | 2004-08-09 | 2006-02-15 | 赵力 | 可直接压片的木糖醇颗粒及其制法 |
| CN1686089B (zh) * | 2005-05-08 | 2010-08-18 | 北京健健康康生物技术有限公司 | 一种可直接压片的木糖醇颗粒及其制备方法 |
| CN101360480B (zh) * | 2005-12-21 | 2015-04-08 | 巴斯夫欧洲公司 | 用于制备快速崩解片剂的药物配制剂 |
| US8425935B2 (en) * | 2005-12-21 | 2013-04-23 | Basf Se | Pharmaceutical formulation for producing rapidly disintegrating tablets |
| BRPI0811303A2 (pt) * | 2007-05-08 | 2015-01-27 | Hercules Inc | Formulação de comprimido de desintegranção rápida robusta |
| CN102046147B (zh) * | 2007-06-06 | 2013-03-20 | 巴斯夫欧洲公司 | 用于制备快速崩解的片剂的药物配制剂 |
-
2012
- 2012-03-06 WO PCT/EP2012/053771 patent/WO2012119997A1/de not_active Ceased
- 2012-03-06 JP JP2013557067A patent/JP2014507454A/ja not_active Ceased
- 2012-03-06 BR BR112013022017A patent/BR112013022017A2/pt not_active IP Right Cessation
- 2012-03-06 CN CN201280012068.0A patent/CN103415284B/zh not_active Expired - Fee Related
- 2012-03-06 EP EP12706862.5A patent/EP2683365A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN103415284A (zh) | 2013-11-27 |
| EP2683365A1 (de) | 2014-01-15 |
| WO2012119997A1 (de) | 2012-09-13 |
| JP2014507454A (ja) | 2014-03-27 |
| CN103415284B (zh) | 2016-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX346224B (es) | Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias. | |
| GT201400069A (es) | Composiciones farmaceuticas | |
| CL2014003566A1 (es) | Compuestos derivados de 7h-pirrolo[2,3-d]pirimidinas 4-(amimo-sustituidas), inhibidores de lrrk2; composicion farmaceutica que los comprende; y metodo para tratar la enfermedad de parkinson. | |
| JO3091B1 (ar) | مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها | |
| CR20130598A (es) | Composiciones de nucleasa terapéuticas y métodos | |
| UY35210A (es) | Inhibidores de autotaxina | |
| HK1218621A1 (zh) | 用於治疗慢性炎症和炎性疾病的组合物及方法 | |
| DOP2014000115A (es) | Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1 | |
| BR112014024903A2 (pt) | anticorpos biespecíficos contra tweak humanao e il17 humana e seus usos | |
| BR112015020389A8 (pt) | compostos carbazol úteis como inibidores de bromodomínio, seu uso, bem como composição e produto farmacêuticos compreendendo os mesmos | |
| CL2014002324A1 (es) | Metodo para lentificar el avance, demorar o tratar la prediabetes en un paciente con sobrepeso u obeso que comprende la administracion de empagliflozina y uno o varios fármacos antiobesidad y composición farmacéutica que comprende a dichos farmacos. | |
| BR112018010018A2 (pt) | moduladores de ror-gama | |
| UY33183A (es) | Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento | |
| GT201200250A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
| BR112013024423A2 (pt) | detecção de doença em plantas | |
| BRPI0812064B8 (pt) | formulação farmacêutica na forma de aglomerados, comprimidos, e, processo para a produção de uma formulação farmacêutica | |
| MX2015009104A (es) | Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares. | |
| EA201590161A1 (ru) | Составы этанерцепта, отличающиеся заметным уменьшением содержания частиц довидимого диапазона | |
| DOP2014000255A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
| BR112014029286A2 (pt) | composição cosmética sólida, processo para sua produção, produto e método cosmético | |
| CU20140037A7 (es) | Derivados de estra- 1,3,5(10), 16- tetraen- 3- carboximida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos | |
| CL2015000039A1 (es) | Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis. | |
| GT201500035A (es) | Composición farmacéutica oral en forma de microesferas y proceso de elaboración | |
| BR112013022017A2 (pt) | formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica | |
| BR112013008749A2 (pt) | análogos de ciclosporina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2504 DE 02/01/2019. |